CardiovascularPre-Clinical Release date: 2023/10/4 ■ PDF Download IHJ-301 / iHeart Japan corporation OZTx-556, iPS cell-derived cardiomyocytes for refractory chronic heart failure / Orizuru Therapeutics, Inc.